US2021340554A1PendingUtilityA1
Method for producing genome-modified plants from plant protoplasts at high efficiency
Est. expiryOct 6, 2035(~9.2 yrs left)· nominal 20-yr term from priority
C12N 15/8213C12N 15/8298C12N 2800/80C12N 9/22C12N 15/113C12N 2310/20C12N 15/11C12N 15/8206A01H 6/1472C12N 15/8202C12N 15/8201C12N 15/8207C12N 9/222
67
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a method of increasing the production efficiency of gene-edited plants, regenerated from plant protoplasts, by use of a Cas protein-guide RNA ribonucleoprotein (RNP). According to the present invention, the method of increasing the production efficiency of gene-edited plants makes it possible to efficiently produce target gene-mutated plants and to minimize the introduction of foreign DNA into plants. Thus, the present invention can be very advantageously used in a wide variety of fields, including agriculture, food and biotechnology.
Claims
exact text as granted — not AI-modified1 . A method for increasing the production efficiency of a genome-edited plant from a plant protoplast, comprising the steps of:
(i) editing a genome of the plant protoplast by a direct introduction of a Cas protein-guide RNA ribonucleoprotein (RNP) in which a Cas protein and a guide RNA in the form of naked RNA are pre-assembled into an isolated plant protoplast without using a vector; and (ii) producing a genome-edited plant by regenerating the plant protoplast.
2 . The method of claim 1 , wherein the guide RNA is specific for a DNA encoding a target gene.
3 . The method of claim 2 , wherein the target gene is a Brassinosteroid Insensitive 2 (BIN2) gene or a Glucosinolate-oxoglutarate-dependent dioxygenase homolog (GSL-ALK) gene.
4 . The method of claim 1 , wherein the editing of a genome is performed by knocking-out or knocking-in.
5 . The method of claim 1 , wherein the guide RNA is in the form of a dual RNA comprising a crRNA and a tracrRNA, or a single-chain guide RNA (sgRNA).
6 . The method of claim 5 , wherein the single-chain guide RNA comprises a part of crRNA and a part of tracrRNA.
7 . The method of claim 1 , wherein the Cas protein is a Cas9 protein or a variant of Cas9 Protein in which the catalytic aspartate residue is substituted with another amino acid.
8 . The method of claim 1 , wherein the Cas protein recognizes NGG trinucleotide.
9 . The method of claim 1 , wherein the Cas protein is linked to a protein transduction domain.
10 . The method of claim 7 , wherein the amino acid is alanine.
11 . The method of claim 1 , wherein the Cas9 protein is derived from the genus Streptococcus.
12 . The method of claim 11 , wherein the genus Streptococcus is Streptococcus pyogenes.
13 . The method of claim 1 , wherein the plant protoplast is derived from Lactuca sativa or Brassica oleracea.
14 . The method of claim 1 , wherein the introduction is performed by the method selected from the group consisting of microinjection, electroporation, DEAE-dextran treatment, lipofection, nanoparticle-mediated transfection, protein transduction domain-mediated transduction, and PEG-mediated transfection.
15 . A plant regenerated from the genome-edited plant protoplast produced by the method of claim 1 .Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.